- Member Benefits
- Manage your personalised Watchlist.
- Set up an online Virtual Portfolio.
- Participate in Share Chat.
- See more trades and director dealings.
- Play the Fantasy Share Trading Game.
Share:
HomeShare PricesStock PickerFinancial DiaryUK IndicesUK Industry SectorsCompany LookupShare RisersShare FallersBroker RatingsFinance GlossarySMS ServicesShare ChatFinance NewsBlogsLive PricesShares BookshopFinance ToolsMembers
Latest Share Chat
Physiomics Share News (PYC)
Share News for Physiomics (PYC)
| Share Price: 0.115 | Bid: 0.09 | Ask: 0.11 | Change: 0.015 (+15.00%) |  | ||||||
| ||||||||||
Physiomics says to perform 2 more oncology projects for Eli Lilly
Mon, 14th Jul 2008 08:17
LONDON (Thomson Financial) - Physiomics Plc. said it has agreed to perform two new cancer drug
The Oxford-based systems biology company said the agreement follows the completion of another cancer drug discovery project for Eli Lilly earlier this year for drug candidates targeting the cell cycle.
tf.TFN-Europe_newsdesk@thomson.com
jrr
COPYRIGHT
Copyright Thomson Financial News Limited 2008. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.
LONDON (Thomson Financial) - Physiomics Plc. said it has agreed to perform two new cancer drug
discovery research projects for Eli Lilly.
The Oxford-based systems biology company said the agreement follows the completion of another cancer drug discovery project for Eli Lilly earlier this year for drug candidates targeting the cell cycle.
tf.TFN-Europe_newsdesk@thomson.com
jrr
COPYRIGHT
Copyright Thomson Financial News Limited 2008. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.
BRIEF-Physiomics comments on share price movement
LONDON, Aug 7 (Reuters) - Physiomics PLC: * Stmnt re share price movement * There are no agreements in existence between sareum,physio[7 Aug '12]
BRIEF-Physiomics notes positive results for VAL 201
LONDON, May 29 (Reuters) - Physiomics PLC: * Statement re share price movement * Notes ValiRx Plc has today announced some positive re[29 May '12]
BRIEF-Physiomics says knows no reason for share price move
LONDON, Feb 15 (Reuters) - Physiomics PLC: * Stmnt re share price movement * Not aware of any reason for the change in share price[15 Feb '11]
STOCKS NEWS UK-Small cap pharmas buoyed by Sareum
STOCKS NEWS Reuters Europe Real-time Equity News UK Stocks on the[9 Feb '11]
BRIEF-Physiomics unaware of reason for share price rise
LONDON, Feb 8 (Reuters) - Physiomics Plc: * Stmnt re share price movement * Directors can confirm that they are not aware of any reaso[8 Feb '11]
BRIEF-Physiomics knows no reason for share price move
LONDON, Sept 22 (Reuters) - Physiomics Plc: * Know of no reason for the recent movements in the company's share price * Actively progr[22 Sep '10]
BRIEF-Physiomics knows no reason for share price move
LONDON, Oct 16 (Reuters) - Physiomics Plc: * Directors confirm they know of no reason for the recent movements in the company's share price[16 Oct '09]
BRIEF-Physiomics in talks with a number of companies
LONDON, Oct 1 (Reuters) - Physiomics Plc: * Is in discussion with a number of major players in the oncology sector * Expects to be abl[1 Oct '09]
